Dare Bioscience Stock Technical Analysis
| DARE Stock | USD 1.35 -0.10 -6.90% |
As of the 19th of March, Dare Bioscience prints 1.35 per share on the tape. Available indicator data includes Standard Deviation of 3.68, variance of 13.58, and Mean Deviation of 2.43. Market dynamics are evaluated through structured indicator analysis. Indicator dispersion is evaluated across similar market participants.
Dare Bioscience Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Dare, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to DareDare Bioscience's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 10.33 | Strong Buy | 4 | Odds |
Dare Bioscience current and past analyst recommendations are summarized from multiple research sources. The summary includes average consensus context. Individual analyst ratings for Dare should be interpreted in the context of the issuing firm's overall track record on Dare Bioscience and similar companies. Some analysts consistently outperform consensus, while others have historically lagged in their predictive accuracy.
Earnings Share -1.83 | Revenue Per Share | Quarterly Revenue Growth -0.95 | Return On Assets | Return On Equity |
Market capitalization and book value offer complementary views of Dare Bioscience - the first driven by investor sentiment, the second by accounting standards. Dare Bioscience's market capitalization is 19.55 M. The 7.25 P/B ratio shows Dare Bioscience carries a substantial premium over its balance-sheet equity. Enterprise value stands at 576.67 K. Value and price for Dare Bioscience are related but not identical, and they can diverge across cycles. Trading price represents the transaction level agreed by market participants.
The concept of value for Dare Bioscience differs from its quoted price, since each reflects a different lens. For Dare Bioscience, key inputs include a P/B ratio of 7.25, ROE of -25.43%, and revenue of 9.78 K. Dare Bioscience's trading price represents the transaction level agreed by market participants.
What if' Analysis
Backtesting a what-if scenario on Dare Bioscience helps investors see how the stock may have behaved if the position had been entered, held, or resized under different historical assumptions. This becomes more informative when investors use the backtest to challenge timing assumptions rather than to search for a perfect historical entry point.
| 12/19/2025 |
| 03/19/2026 |
An initial 0.00 allocation to Dare Bioscience on December 19, 2025 held through today would earn 0.00 in cumulative gains. This reflects a 0.0% return on investment in Dare Bioscience on balance across 90 days. Dare Bioscience competes with or is related to FibroBiologics Common, Citius Pharmaceuticals, Ainos, Athira Pharma, Aspire BioPharma, Aditxt, and Palisade Bio. This provides context for relative positioning. Dar Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing ... More
Dare Bioscience Momentum Range Indicators Dashboard
Upside/downside measures for Dare Bioscience frame directional pressure and range behavior. This view helps summarize momentum conditions without implying direction.
| Information Ratio | -0.09 | |||
| Maximum Drawdown | 26.52 | |||
| Value At Risk | -5.29 | |||
| Potential Upside | 5.08 |
Market Risk Indicators for Dare Bioscience Summary
Risk measures here provide context on Dare Bioscience's return distribution and drawdown behavior. The metrics rely on historical prices to describe variability over time.| Risk Adjusted Performance | -0.08 | |||
| Jensen Alpha | -0.42 | |||
| Total Risk Alpha | -0.03 | |||
| Treynor Ratio | -6.31 |
Experienced Dare Bioscience's investors use mean reversion as a complement to momentum analysis: momentum identifies the trend; mean reversion identifies when that trend has extended beyond sustainable levels.
Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | -0.08 | |||
| Market Risk Adjusted Performance | -6.30 | |||
| Mean Deviation | 2.43 | |||
| Coefficient Of Variation | -890.34 | |||
| Standard Deviation | 3.68 | |||
| Variance | 13.58 | |||
| Information Ratio | -0.09 | |||
| Jensen Alpha | -0.42 | |||
| Total Risk Alpha | -0.03 | |||
| Treynor Ratio | -6.31 | |||
| Maximum Drawdown | 26.52 | |||
| Value At Risk | -5.29 | |||
| Potential Upside | 5.08 | |||
| Skewness | 1.8 | |||
| Kurtosis | 9.23 |
Dare Bioscience Backtested Returns
Dare Bioscience holds a moderate volatility within the selected horizon. It shows a risk-adjusted return measure of -0.24, defining negative risk-normalized returns. We identified twenty-three technical indicators influencing the company's volatility profile. Please examine metrics such as standard deviation of 3.68, variance of 13.58, and mean deviation of 2.43 to confirm risk-return consistency. The company has a beta of 0.0672, which indicates relatively modest fluctuations relative to the market. With a sub-1 beta, Dare Bioscience participates in market rallies at a reduced pace while also limiting downside exposure. At this point, Dare Bioscience has a negative expected return of -0.58%. Please make sure to check Dare Bioscience's the relationship between the kurtosis and market facilitation index, to decide if Dare Bioscience's performance from the past will be repeated at some future point.
Auto-correlation | 0.72 |
Good predictability
The autocorrelation profile for Dare Bioscience registers good predictability between the two measured intervals. When lagged price patterns show consistency, they can serve as a partial input for modeling Dare Bioscience's near-term price behavior. A serial correlation of 0.72 indicates that around 72.0% of current Dare Bioscience price fluctuations can be explained by its historical price movements.
| Correlation Coefficient | 0.72 | |
| Spearman Rank Test | 0.58 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Dare Bioscience technical stock analysis uses price and volume transformations to study behavior. The analysis highlights moving averages, RSI, and price correlation signals across the stock cycle.
Technical Analysis
This analysis covers thirty-seven data points across the selected time horizon. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Dare Bioscience volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Technical Analysis Methodology & Indicators
Technical analysis of Dare Bioscience evaluates price structure, momentum, and volatility clustering. Momentum regimes can shift quickly when liquidity conditions change. Dare Bioscience has a market cap of 19.55 M, ROE of -25.43%.
Macroaxis compiles Dare Bioscience metrics from periodic company reporting and market reference feeds and applies consistent transformation rules before display. Not all fields update in real time.
This content is curated and reviewed by:
Gabriel Shpitalnik - Member of Macroaxis Editorial BoardDare Bioscience Technical Indicators
A technical review of Dare Bioscience can improve timing discipline by comparing momentum, reversal risk, and confirmation signals across several time horizons. A disciplined technical workflow helps investors separate stronger setups from noisier price action.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | -0.08 | |||
| Market Risk Adjusted Performance | -6.30 | |||
| Mean Deviation | 2.43 | |||
| Coefficient Of Variation | -890.34 | |||
| Standard Deviation | 3.68 | |||
| Variance | 13.58 | |||
| Information Ratio | -0.09 | |||
| Jensen Alpha | -0.42 | |||
| Total Risk Alpha | -0.03 | |||
| Treynor Ratio | -6.31 | |||
| Maximum Drawdown | 26.52 | |||
| Value At Risk | -5.29 | |||
| Potential Upside | 5.08 | |||
| Skewness | 1.8 | |||
| Kurtosis | 9.23 |
March 19, 2026 Daily Trend Indicators
A technical review of Dare Bioscience can improve timing discipline by comparing momentum, reversal risk, and confirmation signals across several time horizons. A disciplined technical workflow helps investors separate stronger setups from noisier price action.
| Accumulation Distribution | 0.09 | ||
| Daily Balance Of Power | -0.77 | ||
| Rate Of Daily Change | 0.93 | ||
| Day Median Price | 1.42 | ||
| Day Typical Price | 1.39 | ||
| Price Action Indicator | -0.11 | ||
| Market Facilitation Index | 0.13 |
Popular Tools for Dare Stock analysis
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |